Skip to main content
Premium Trial:

Request an Annual Quote

Hologic Acquisition of Third Wave Gets Antitrust Clearance

NEW YORK (GenomeWeb News) – Hologic said today that its proposed $580 million acquisition of Third Wave Technologies has received from the Federal Trade Commission early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
 
Hologic announced two weeks ago that it will acquire Third Wave Technologies for $11.25 per share, a 24 percent premium to Third Wave’s average trading price during the preceding three months. 
 
The tender offer is scheduled to expire at midnight, New York City time, on July 16, 2008. The boards of directors of both firms have unanimously approved the transaction, and the companies expect to complete the deal in the third quarter of 2008.